| 标题 |
1789P Second OS interim analysis from BEAT-SC: A randomized phase III study of bevacizumab (bev) or placebo in combination with atezolizumab and platinum-based chemotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:B. Han; Y. Ohe; M. Nishio; S. Watanabe; X. Ren; et al 出版日期:2024-09-18 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)